COM:GILEAD
Gilead Sciences, Inc.
- Stock
Last Close
89.76
22/11 21:00
Market Cap
85.65B
Beta: -
Volume Today
4.43M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
revenue | 24.89B - | 32.64B 31.13% | 30.39B 6.89% | 26.11B 14.09% | 22.13B 15.24% | 22.45B 1.46% | 24.69B 9.98% | 27.30B 10.60% | 27.28B 0.09% | 27.12B 0.60% | |
cost of revenue | 3.79B - | 4.01B 5.76% | 4.26B 6.37% | 4.37B 2.58% | 4.85B 11.03% | 4.67B 3.67% | 4.57B 2.20% | 6.60B 44.38% | 5.66B 14.30% | ||
gross profit | 21.10B - | 28.63B 35.69% | 26.13B 8.75% | 21.74B 16.81% | 17.27B 20.53% | 17.77B 2.89% | 20.12B 13.18% | 20.70B 2.92% | 21.62B 4.44% | 27.12B 25.40% | |
selling and marketing expenses | |||||||||||
general and administrative expenses | 2.98B - | 3.43B 14.85% | 3.40B 0.82% | 3.88B 14.13% | 4.06B 4.59% | ||||||
selling general and administrative expenses | 2.98B - | 3.43B 14.85% | 3.40B 0.82% | 3.88B 14.13% | 4.06B 4.59% | 4.38B 8.01% | 5.15B 17.58% | 5.25B 1.84% | 5.67B 8.14% | 6.09B 7.35% | |
research and development expenses | 2.85B - | 3.01B 5.61% | 5.10B 69.14% | 3.73B 26.76% | 5.02B 34.39% | 9.11B 81.47% | 5.04B 44.66% | 5.36B 6.43% | 4.98B 7.20% | 5.72B 14.89% | |
other expenses | 3M - | 154M 5,033.33% | 428M 177.92% | 523M 22.20% | 676M 29.25% | 1.87B 176.33% | -1.42B 175.91% | -639M 54.94% | -581M 9.08% | ||
cost and expenses | 9.63B - | 10.45B 8.53% | 12.76B 22.12% | 11.98B 6.07% | 13.93B 16.22% | 18.16B 30.41% | 14.76B 18.72% | 17.21B 16.58% | 16.31B 5.25% | 19.51B 19.65% | |
operating expenses | 5.84B - | 6.44B 10.33% | 8.50B 31.93% | 7.61B 10.40% | 9.07B 19.21% | 13.49B 48.63% | 10.19B 24.45% | 10.61B 4.11% | 10.65B 0.39% | 11.81B 10.87% | |
interest expense | 412M - | 688M 66.99% | 964M 40.12% | 1.12B 15.98% | 1.08B 3.67% | 995M 7.61% | 984M 1.11% | 1.00B 1.73% | 935M 6.59% | -944M 200.96% | |
ebitda | 15.27B - | 22.35B 46.36% | 18.06B 19.18% | 14.65B 18.90% | 8.88B 39.40% | 6.16B 30.66% | 8.51B 38.25% | 9.46B 11.13% | 10.39B 9.91% | 7.61B 26.83% | |
operating income | 15.27B - | 22.19B 45.38% | 17.63B 20.55% | 14.12B 19.90% | 8.20B 41.94% | 4.29B 47.72% | 7.03B 63.96% | 7.41B 5.36% | 7.33B 1.03% | 7.61B 3.75% | |
depreciation and amortization | 1.05B - | 1.10B 4.57% | 1.16B 5.46% | 1.29B 11.05% | 1.43B 11.12% | 1.87B 30.72% | 1.48B 20.77% | 2.05B 38.51% | 3.06B 49.41% | ||
total other income expenses net | 3M - | 154M 5,033.33% | 428M 177.92% | 523M 22.20% | 676M 29.25% | 873M 29.14% | -5.36B 713.97% | 872M 116.27% | -1.52B 273.85% | -746M 50.79% | |
income before tax | 14.86B - | 21.66B 45.79% | 17.10B 21.06% | 13.53B 20.87% | 7.80B 42.35% | 5.16B 33.84% | 1.67B 67.66% | 8.28B 395.99% | 5.81B 29.77% | 6.86B 17.97% | |
income tax expense | 2.80B - | 3.55B 27.03% | 3.61B 1.58% | 8.88B 146.19% | 2.34B 73.67% | -204M 108.72% | 1.58B 874.51% | 2.08B 31.46% | 1.25B 39.91% | -1.25B 199.92% | |
net income | 12.10B - | 18.11B 49.64% | 13.50B 25.44% | 4.63B 65.72% | 5.46B 17.87% | 5.39B 1.26% | 89M 98.35% | 6.22B 6,894.38% | 4.59B 26.23% | 5.67B 23.37% | |
weighted average shs out | 1.52B - | 1.46B 3.81% | 1.34B 8.54% | 1.31B 2.39% | 1.30B 0.69% | 1.27B 2.16% | 1.26B 1.02% | 1.26B 0.08% | 1.25B 0.08% | 1.25B 0.56% | |
weighted average shs out dil | 1.65B - | 1.52B 7.65% | 1.36B 10.72% | 1.32B 2.87% | 1.31B 0.83% | 1.28B 2.37% | 1.26B 1.10% | 1.26B 0.08% | 1.26B 0% | 1.26B 0.32% | |
eps | 7.95 - | 12.37 55.60% | 10.08 18.51% | 3.54 64.88% | 4.20 18.64% | 4.24 0.95% | 0.07 98.33% | 4.96 6,905.65% | 3.66 26.21% | 4.54 24.04% | |
epsdiluted | 7.35 - | 11.91 62.04% | 9.94 16.54% | 3.51 64.69% | 4.17 18.80% | 4.22 1.20% | 0.07 98.33% | 4.93 6,892.91% | 3.64 26.17% | 4.50 23.63% |
All numbers in USD (except ratios and percentages)